Literature DB >> 14679490

Preserved diffusion capacity in children with cystic fibrosis.

Peter J F M Merkus1, Elke S J Govaere, Wim H Hop, Henk Stam, Harm A W M Tiddens, Johan C de Jongste.   

Abstract

Early detection of progressive lung disease in cystic fibrosis (CF) may lead to better treatment and prognosis. Routine lung function indices may be relatively insensitive markers of peripheral airway obstruction and alveolar collapse. We hypothesized that the single-breath diffusion capacity of the lung for carbon monoxide (DLCO) would change before tests of airway function in patients with CF. We assessed lung function longitudinally in 53 children with CF during a mean period of 3.8 years to determine whether the diffusion capacity of the lung becomes abnormal before more conventional indices of lung function do. Within patients, DLCO was slightly elevated and remained stable, while forced expired volume in 1 sec (FEV1) and forced vital capacity (FVC) declined progressively (mean individual decline, -1.8% and -0.8% of predicted). Cross-sectionally, this decline was faster (mean group decline -3.8% and -2.8% of predicted), indicating an additional cohort effect. Normalized diffusion capacity at an early stage of CF is slightly elevated and is preserved in spite of progressive obstructive lung disease. This can be attributed to alterations in pulmonary and bronchial circulation due to loss of function and/or number of alveolar units. Diffusion capacity at rest does not appear to be a suitable early marker of progressive deterioration of CF lung disease. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14679490     DOI: 10.1002/ppul.10357

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  Improving rate of decline of FEV1 in young adults with cystic fibrosis.

Authors:  C Que; P Cullinan; D Geddes
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

2.  Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.

Authors:  Holger Dressel; Laura Filser; Rainald Fischer; Katharina Marten; Ullrich Müller-Lisse; Dorothea de la Motte; Dennis Nowak; Rudolf M Huber; Rudolf A Jörres
Journal:  BMC Pulm Med       Date:  2009-06-16       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.